Hydromorphone polymer implant A potential alternative to methadone maintenance

Rhodes, Deborah J.; Grossman, Stuart A.

doi:10.1016/s0740-5472(97)00117-7

Cited by 11 publications

(6 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For severe pain, slow release systems for potent opioids have been described. Subcutaneous hydromorphine implants have been used both in pain control and treatment of addiction, and systems releasing drugs for up to 8 weeks have been developed (32, 33). Liposomal slow release forms of opioids such as morphine have also been obtained (34).…”

Section: Discussionmentioning

confidence: 99%

Tramadol encapsulated into polyhydroxybutyrate microspheres: in vitro release and epidural analgesic effect in rats

Salman

Sahin

Onur

et al. 2003

Acta Anaesthesiol Scand

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Tramadol encapsulated into polyhydroxybutyrate microspheres: in vitro release and epidural analgesic effect in rats

Salman

Sahin

Onur

et al. 2003

Acta Anaesthesiol Scand

View full text Add to dashboard Cite

show abstract

“…Although most cancer pain can be readily managed with oral analgesic therapy, cancer pain has often been inaccurately assessed, undertreated, and inadequately managed (Chan & Woodruff, 1997;Rhodes & Grossman, 1997). For systematic and adequate cancer pain management, the World Health Organization (WHO) has created a Cancer Pain Relief Program and developed guidelines for the treatment of cancer pain, the American Pain Society (APS) suggested Quality Assurance Standards on Acute Pain and Cancer Pain, and the Agency for Health Care Policy and Research (AHCPR) pain panel also developed and suggested guidelines for cancer pain management (AHCPR, 1994;APS, 1995;WHO, 1996).…”

mentioning

confidence: 99%

A Feminist Critique of Research on Cancer Pain

Chee

2001

West J Nurs Res

View full text Add to dashboard Cite

A number of studies on cancer pain have been conducted but the researchers rarely considered gender and ethnic differences in cancer pain. In this article, nursing research on cancer pain is critiqued from a feminist perspective, and directions for future nursing research are proposed. A total of 82 nursing articles published in the United States were retrieved through MEDLINE and MELVYL data retrieval systems, and analyzed and critiqued in terms of four basic elements of research from a feminist perspective (bias as resources, dependability, credibility and adequacy, and intersubjectivity). In this article, the critique is presented with four themes that may provide reasons why nursing research on cancer pain rarely incorporated gender and ethnic differences: absence of participants' own views and experiences, androcentrism and ethnocentrism, lack of consideration on contextual factors, and distant relationships between researchers and research participants. To overcome the limitations, six critical elements including gender and ethnic sensitivity, avoidance of distorted views, respectfor participants' own views and interests, trust and openness, empowerment, and multiple methods are suggested to be incorporated in future nursing research on cancer pain.

show abstract

“…For example, the MOP-R agonist methadone, which is used to treat heroin addiction, has been reported to be widely abused Simonsen et al, 2011a;Simonsen et al, 2011b;Tormoehlen et al, 2011). Although the use of "substitution" therapy with opioid agonists has been effective for some patients, it has remained controversial (Gerra et al, 2009;Ling et al, 1994;Rhodes & Grossman, 1997). However, as naltrexone induces aversive side-effects in humans and conditioned place aversion in rats (Mitchell et al, 2009), it does not appear to be rewarding itself.…”

Section: Abuse Potentialmentioning

confidence: 99%